![Gregory Ciongoli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 13 M $ al 30/06/2026
Gregory A. Ciongoli is the founder of Adiumentum Capital Management LLC.
Mr. Ciongoli is currently Chairman at Atara Biotherapeutics, Inc. starting in 2025 and Director at Zymeworks, Inc. starting in 2025.
Mr. Ciongoli was a Partner at The Baupost Group LLC.
Mr. Ciongoli earned an MBA from Harvard Business School and completed undergraduate studies at the Woodrow Wilson School of Public & International Affairs.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZYMEWORKS INC. 0,68 % | 12/01/2026 | 493.500 ( 0,68 % ) | 13 M $ | 30/06/2026 |
| 09/06/2026 | 12.000 ( 0,13 % ) | 137 760 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Presidente | 03/09/2025 |
| ZYMEWORKS INC. | Director/Miembro de la Junta | 11/08/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
The Baupost Group LLC
 The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
The Baupost Group LLC
The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Woodrow Wilson School of Public & International Affairs
 Woodrow Wilson School of Public & International Affairs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
